The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: Results of a longitudinal, web-based study

International Journal of Drug Policy

Volumn 24, Issue 5, 2013, Pages 412-422

  Sheridan, Janie ^a   Dong, Christine Yang ^a   Butler, Rachael ^a   Barnes, Joanne ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Benzylpiperazine (BZP); Drug policy; Prohibition; Young people

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; BENZYLPIPERAZINE; CENTRAL STIMULANT AGENT; ILLICIT DRUG; PIPERAZINE DERIVATIVE; PRESCRIPTION DRUG; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG CONTROL; DRUG MISUSE; FEMALE; GOVERNMENT REGULATION; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; INTERNET; LONGITUDINAL STUDY; MALE; NEW ZEALAND; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BENZYLPIPERAZINE (BZP); DRUG POLICY; PROHIBITION; YOUNG PEOPLE;

ADOLESCENT; ADULT; DRUG AND NARCOTIC CONTROL; FEMALE; HUMANS; INTERNET; LONGITUDINAL STUDIES; MALE; NEW ZEALAND; PIPERAZINES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84884594222     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.02.002     Document Type: Article

References (52)

1. Alansari M., Hamilton D. Nephrotoxicity of BZP-based herbal party pills: A New Zealand case report. New Zealand Medical Journal 2006, 119(May (1233)):U1959.
2. Antia U., Tingle M., Russell B. In vivo interactions between BZP and TFMPP (party pill drugs). New Zealand Medical Journal 2009, 122(1303). http://journal.nzma.org.nz/journal/122-1303/3794/.
3. Baumann M.H., Clark R.D., Budzynski A.G., Partilla J.S., Blough B.E., Rothman R.B. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain. Annals of the New York Academy of Sciences 2004, 1025. 189/197.
4. Berney-Meyer L., Putt T., Schollum J., Walker R. Nephrotoxicity of recreational party drugs. Nephrology 2012, 17(2):99-103.
5. Birnbaum M. Human reserach and data collection via the internet. Annual Review of Psychology 2004, 55:803-832.
6. Bryson K., Wilson M. Recreational drug using behaviour and legal BZP party pills report to the national drug policy 2007, School of Psychology, Victoria University of Wellington, Wllington.
7. Butler R., Sheridan J. Highs and lows: Patterns of use, positive and negative effects of benzylpiperazine-containing party pills (BZP-party pills) amongst young people in New Zealand. Harm Reduction Journal 2007, 4(18). 10.1186/1477-7517-1184-1118.
8. Campbell H., Cline W., Evans M., Lloyd J., Peck A.W. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. European Journal of Clinical Pharmacology 1973, 6(3):170-176.
9. Cohen B.M.Z., Butler R. BZP-party pills: A review of research on benzylpiperazine as a recreational drug. The International Journal on Drug Policy 2011, 22(2):95-101.
10. Corazza C., Demetrovics Z., van den Brink W., Schifano F. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. International Journal of Drug Policy 2013, 24(1):82-83.
11. Davey Z., Corazza O., Schifano F., Deluca P. Mass-information: Mephedrone, myths, and the new generation of legal highs. Drugs and Alcohol Today 2010, 10(3):24-28.
12. European Monitoring Centre for Drugs and Drug Addiction. (2008a). Survey of online shops. From . http://www.emcdda.europa.eu/html.cfm/index64334EN.html.
13. European Monitoring Centre for Drugs and Drug Addiction. (2008b). Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. Retrieved from . http://www.emcdda.europa.eu/attachements.cfm/att_70975_EN_EMCDDA_risk_assessment_8.pdf.
14. Gee P., Fountain J. Party on? BZP party pills in New Zealand. New Zealand Medical Journal 2007, 120(1249):508.
15. Gee P., Richardson S., Woltersdorf W., Moore G. Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand. New Zealand Medical Journal 2005, 118(1227.).
16. Green J.A. Partying on? Life after BZP-based party pills. New Zealand Medical Journal 2008, 121(1283):35-42.
17. Hayslett M.M., Wildemuth B.M. Pixels or pencils? The relative effectiveness of web-based versus paper surveys. Library and Information Science Research 2004, 26(1):73-93.
18. Hillebrand J., Olszewski D., Sedefov R. Legal highs on the internet. Substance Use & Misuse 2010, 45(3):330-340.
19. Jan R., Lin J., Lee H.S., Sheridan J., Kydd R.R., Kirk I., et al. Determining the subjective effects of TFMPP in human males. Psychopharmacology 2011, 211(3):347-353.
20. Lin J., Jan R., Lee H., Jensen M.-A., Kydd R., Russell B. Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology 2011, 214(3):761-768.
21. Manchikanti L. Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 2006, 9(4):287-321.
22. Measham F., Moore K., Newcombe N., Welch Z. Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drug and Alcohol Today 2010, 14-21. 10.5042/daat.2010.0123.
23. Ministerial Action Group on Drugs Methamphetamine action plan 2003, Ministerial Action Group on Drugs, Wellington.
24. Ministry of Health Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey 2010, Ministry of Health, Wellington.
25. Ministry of Health Regulatory Impact Statement - New regulatory regime for psychoactive substances 2012, Ministry of Health, Wellington.
26. Misuse of Drugs Classification of BZP Amendment Bill. (2008).
27. Newcombe R. Mephedrone: The use of mephedrone (M-cat, Meow) in middlesbrough 2009, Lifeline Publications and Research, Manchester.
28. Nikolova I., Danchev N. Piperazine based substances of abuse: A new party pills on bulgarian drug market. Biotechnology and Biotechnological Equipment 2008, 22(2):652-655.
29. Rhodes S.D., Bowie D.A., Hergenrather K.C. Collecting behavioural data using the world wide web: Considerations for researchers. Journal of Epidemiology and Community Health 2003, 57(1):68-73.
30. Sheridan J., Atmore B., Russell B. New Zealand to establish fit for purpose regulation for new psychoactive substances. Addiction 2012, 107(11):1901-1902.
31. Sheridan J., Butler R. Legal party pills and their use by young people in New Zealand: A qualitative study. Final report of findings 2006, University of Auckland, Auckland.
32. Sheridan J., Butler R. Legally available, unclassified psychoactive substances and illegal drugs in New Zealand before and after the ban on BZP: A web-based survey of patterns of use. Final report of findings 2009, The University of Auckland, Auckland, New Zealand.
33. Sheridan J., Butler R. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?. International Journal of Drug Policy 2010, 21(1):77-81.
34. Sheridan J., Butler R., Wilkins C., Russell B. Legal piperazine-containing party pills - a new trend in substance misuse. Drug and Alcohol Review 2007, 26(3):335-343.
35. Social Statistics Division of Statistics New Zealand Household Access to the Internet 2004, Social Statistics Division of Statistics New Zealand, Wellington.
36. Social Tonics Association of New Zealand. (2005). Submission of Social Tonics Association of New Zealand to the Health Select Committee on the matter of Misuse of Drugs Amendment Bill (No. 3) and the Supplementary Order Paper. STANZ.
37. Statutory Instrument. (2005). Misuse of Drugs Amendment Act.
38. Substance Abuse and Mental Health Services Administration Results from the 2006 national survey on drug use and health: National findings 2007, Office of Applied Studies, Rockville, MD.
39. Theron L., Jansen K., Miles J. Benzylpiperizine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amphetamines, cocaine, and alcohol. New Zealand Medical Journal 2007, 120(1249.).
40. Treasury. (2011). Regulatory Impact Statement - Government Response to the Law Commission's Report "Controlling and Regulating Drugs - A review of the Misuse of Drugs Act 1975". Retrieved from . http://www.treasury.govt.nz/publications/informationreleases/ris/pdfs/ris-moh-card-sep11.pdf.
41. United Nations Research Institute for Social Development. (1994). Illicit Drugs: Social Impacts and Policy Responses, UNRISD Briefing Paper No. 2 World Summit For Social Development Geneva: UNRISD.
42. Wilkins C., Girling M., Sweetsur P. The prevalence of use, dependency and harms of legal party pills containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Use 2007, 12(3):213-224.
43. Wilkins, C., Girling, M., Sweetsur, P., Huckle, T., & Huakau, J. (2006). Legal party pill use in New Zealand: Prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and triflourophenylmethylpiperazine (TFMPP). Retrieved from . http://www.ndp.govt.nz/moh.nsf/pagescm/993/$File/legalpartypillusenz.pdf.
44. Wilkins C., Sweetsur P. The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand. Drug and Alcohol Dependence 2012, 127(1-3):72-80.
45. Wilkins C., Sweetsur P., Girling M. Patterns of benzylpiperazine/trifluoromethylphenylpiperazine party pill use and adverse effects in a population sample in New Zealand. Drug and Alcohol Review 2008, 27(6):633-639.
46. Wilkins C., Sweetsur P., Smart B., Griffiths R. Recent trends in illegal Drug use in New Zealand, 2006-2010. Findings from the 2006, 2007, 2008, 2009 and 2010 illicit drug monitoring system (IDMS) 2011, Social and Health Outcomes Research, and Evaluation (SHORE), Massey University, Auckland.
47. Wilkins, C., Sweetsur, P., Smart, B., Warne, C., & Jawalkar, S. (2012). Recent trends in illegal drug use in New Zealand: Findings from the 2006, 2007, 2008, 2009, 2010 and 2011 Illicit Drug Monitoring System (IDMS). Retrieved from . http://www.massey.ac.nz/massey/fms/Colleges/College%20of%20Humanities%20and%20Social%20Sciences/Shore/reports/IDMS%202011%20Final%20Report.pdf.
48. Winstock A., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J. Mephedrone: Use, subjective effects and health risks. Addiction 2011, 106(11):1991-1996.
49. Winstock A., Ramsey J.D. Legal highs and the challenges for policy makers. Addiction 2010, 105(10):1685-1687.
50. Winstock A.R., Marsden J., Mitcheson L. What should be done about mephedrone?. BMJ 2010, 340(c1605).
51. Winstock A.R., Mitcheson L., Marsden J. Mephedrone: Still available and twice the price. The Lancet 2010, 376(9752):1537.
52. Winstock, A. R., & Wilkins, C. (2011). 'Legal highs': The challenge of new psychoactive substances. Legislative Reform of Drug Policies 16. Retrieved from . http://www.tni.org/sites/www.tni.org/files/download/dlr16.pdf.